The future stems from knowledge
The Danish Stem Cell Center (DanStem) opened in the summer of 2011 and is currently establishing itself as a hub for international basic, translational and early clinical stem cell research. The aim of DanStem is to develop novel therapeutic approaches for diabetes and cancer.

One center - two divisions - more opportunities
The center comprises two separate sections: The Novo Nordisk Foundation Section for Basic Stem Cell Biology (BasicStem) and The Section for Strategic Translational Stem Cell Research and Therapy (TransStem).

BasicStem will focus on basic experimental research into the biology of pluripotent stem cells, the formation of beta cells and the special properties of cancer stem cells. This section is supported by a donation from The Novo Nordisk Foundation.
TransStem will translate promising basic research results into new strategies and targets for the development of new therapies for cancer and diabetes and move these fields towards early clinical application. This section is supported by a grant from The Danish Council of Strategic Research.

Together, the sections will give researchers at DanStem the opportunity to perform cutting-edge basic stem cell research and translate this into novel therapies for two very serious diseases that face societies around the globe – diabetes and cancer.